BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2026 6:38:35 AM | Browse: 4 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 120873
Country China
Received
2026-03-11 03:36
Peer-Review Started
2026-03-11 03:36
First Decision by Editorial Office Director
2026-03-20 11:42
Return for Revision
2026-03-20 11:42
Revised
2026-04-11 00:14
Publication Fee Transferred
Second Decision by Editor
2026-05-07 03:22
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-05-07 06:24
Articles in Press
2026-05-07 06:24
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-08-03 07:55
Publish the Manuscript Online
2026-08-25 06:38
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title N6-methyladenosine RNA methylation in relation to the inflammatory response, immunity and the intestinal microbiota in inflammatory bowel disease
Manuscript Source Invited Manuscript
All Author List Lie Zheng and Sheng-Lei Duan
ORCID
Author(s) ORCID Number
Lie Zheng http://orcid.org/0009-0007-2432-1414
Sheng-Lei Duan http://orcid.org/0000-0002-4151-1718
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China No. 82574996
Shaanxi Province Traditional Chinese Medicine Research and Innovation Talent Plan Project No. TZKN-CXRC-16
Project of Shaanxi Administration of Traditional Chinese Medicine No. SZY-KJCYC-2025-JC-010
Shaanxi Province Key Research and Development Plan Project-Social Development Field No. 2025SF-YBXM-498
The “Nursery Cultivation Plan” project of Shaanxi Provincial Academy of Chinese Medicine and Shaanxi Provincial Hospital of Traditional Chinese Medicine for the year 2025 No. 2025-04
The Fifth Batch of Outstanding Clinical Talents in Traditional Chinese Medicine Project of Shaanxi Province, Shaanxi Traditional Chinese Medicine Letter [2025] No. 6
Corresponding Author Sheng-Lei Duan, Department of Gastroenterology, Shaanxi Hospital of Traditional Chinese Medicine, No. 4 Xihuamen, Xi’an 710003, Shaanxi Province, China. 281930369@qq.com
Key Words N6-methyladenosine; RNA methylation; Immunity; Intestinal microbiota; Inflammatory bowel disease
Core Tip Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the intestine. N6-methyladenosine (m6A) RNA methylation, which is the most abundant messenger RNA modification in mammalian cells, plays an important role in IBD by influencing various processes, such as RNA stability, splicing, translation, and degradation, and participating in the pathogenesis of IBD. The key enzymes involved in m6A methylation (such as methyltransferase-like 3, methyltransferase-like 4 and fat mass and obesity-associated protein) not only regulate changes in inflammation and immunity in IBD but also bidirectionally regulate the intestinal microenvironment. However, the specific mechanism of m6A methylation modification in IBD needs further exploration. Future research should focus on clarifying the molecular network related to m6A methylation and IBD to provide new intervention methods for clinical practice and improve the outcomes of IBD patients. This article reviews the research progress on m6A RNA methylation in IBD, aiming to improve the understanding of IBD pathogenesis at the epigenetic level and provide new directions for exploring treatments targeting m6A-modified related proteins for IBD.
Publish Date 2026-08-25 06:38
Citation

Zheng L, Duan SL. N6-methyladenosine RNA methylation in relation to the inflammatory response, immunity and the intestinal microbiota in inflammatory bowel disease. World J Gastroenterol 2026; 32(36): 120873

URL https://www.wjgnet.com/1007-9327/full/v32/i36/120873.htm
DOI https://doi.org/10.3748/wjg.120873
Full Article (PDF) WJG-32-120873-with-cover.pdf
Manuscript File 120873_Auto_Edited_024610.docx
Answering Reviewers 120873-answering-reviewers.pdf
Audio Core Tip 120873-audio.m4a
Conflict-of-Interest Disclosure Form 120873-conflict-of-interest-statement.pdf
Copyright License Agreement 120873-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate 120873-non-native-speakers.pdf
Peer-review Report 120873-peer-reviews.pdf
Scientific Misconduct Check 120873-scientific-misconduct-check.png
CrossCheck Report 120873-crosscheck-report.pdf